Cargando…
Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines–Early experience with vaccine rollout in a multi-site healthcare system
BACKGROUND: Hesitancy and incomplete vaccination against coronavirus disease 2019 (COVID-19) remains an obstacle to achieving herd immunity. Because of fear of vaccine reactions, patients with medical and allergic co-morbidities express heightened hesitancy. Limited information is available to guide...
Autores principales: | Al-Obaydi, Sarah, Hennrikus, Eileen, Mohammad, Nazar, Lehman, Erik B., Thakur, Abhishek, Al-Shaikhly, Taha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355214/ https://www.ncbi.nlm.nih.gov/pubmed/35930586 http://dx.doi.org/10.1371/journal.pone.0272691 |
Ejemplares similares
-
COVID-19 vaccine rollout: will it affect the rates of vaccine hesitancy in Africa?
por: Ekwebelem, O.C., et al.
Publicado: (2021) -
COVID-19 Vaccination Rollout: Aspects of Hesitancy in South Africa
por: Steenberg, Bent, et al.
Publicado: (2023) -
Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
por: Dluzynski, Daniela, et al.
Publicado: (2023) -
Hesitancy, reactogenicity and immunogenicity of the mRNA and whole-virus inactivated Covid-19 vaccines in pediatric neuromuscular diseases
por: Yu, Michael Kwan Leung, et al.
Publicado: (2023) -
COVID-19 Vaccine Hesitancy and Uptake among Nursing Staff during an Active Vaccine Rollout
por: Baniak, Lynn M., et al.
Publicado: (2021)